EAM
CMPS

Exome Asset Management’s Compass Pathways CMPS Stock Holding History

Exome Asset Management’s Portfolio CMPS Stock Details CMPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-213,544
Closed -$598K – 78
2025
Q2 		$598K Buy
+213,544
New +$804K 0.44% 51

Other funds holding CMPS

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Exome Asset Management's CMPS Position: Q3 2025 in Review

Exome Asset Management sold out of Compass Pathways (CMPS) in Q3 2025, closing a stake of 213,544 shares — an estimated $598K sold.

Exome Asset Management first reported a position in CMPS in Q2 2025 and held it in 1 quarter. The position peaked at $598K in Q2 2025. 157 funds tracked by Wall St. Rank hold CMPS as of Q3 2025.

  • Exome Asset Management reported no remaining Compass Pathways position as of Q3 2025 after selling out during the quarter.
  • Exome Asset Management sold 213,544 Compass Pathways shares in Q3 2025, an estimated $598K.
  • Exome Asset Management first reported a position in Compass Pathways in Q2 2025 and held it in 1 quarter.
  • Exome Asset Management's Compass Pathways position peaked at $598K in Q2 2025.
  • 157 funds tracked by Wall St. Rank held Compass Pathways as of Q3 2025.

Based on Exome Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.